Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2003

01-03-2003

The Prognostic Value of the Human Kallikrein Gene 9 (KLK9) in Breast Cancer

Authors: George M. Yousef, Andreas Scorilas, Terukazu Nakamura, Mohamed Abd Ellatif, Riccardo Ponzone, Nicoletta Biglia, Furio Maggiorotto, Riccardo Roagna, Piero Sismondi, Eleftherios P. Diamandis

Published in: Breast Cancer Research and Treatment | Issue 2/2003

Login to get access
Metadata
Title
The Prognostic Value of the Human Kallikrein Gene 9 (KLK9) in Breast Cancer
Authors
George M. Yousef
Andreas Scorilas
Terukazu Nakamura
Mohamed Abd Ellatif
Riccardo Ponzone
Nicoletta Biglia
Furio Maggiorotto
Riccardo Roagna
Piero Sismondi
Eleftherios P. Diamandis
Publication date
01-03-2003
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 2/2003
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1022931403825

Other articles of this Issue 2/2003

Breast Cancer Research and Treatment 2/2003 Go to the issue

Instructions for Authors

Instructions for Authors

OriginalPaper

Breast Cell Proliferation in Postmenopausal Women During HRT Evaluated Through Fine Needle Aspiration Cytology

OriginalPaper

Estrogen-Induced Ets-1 Promotes Capillary Formation in an in vitro Tumor Angiogenesis Model

OriginalPaper

Estradiol Enhances Osteolytic Lesions in Mice Inoculated with Human Estrogen Receptor-Negative MDA-231 Breast Cancer Cells in vivo

Announcement

Announcement: 2nd Annual CANCER VACCINES 2003 – Advances in Designing

OriginalPaper

Canine Inflammatory Mammary Carcinoma: Histopathology, Immunohistochemistry and Clinical Implications of 21 Cases
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits